Dialysis Patients' Perspectives: A Study of the Q Methodology

March 11, 2026 updated by: Yavuz Uren, Yuzuncu Yil University
This study was conducted to systematically examine the subjective experiences and perspectives of dialysis patients regarding their treatment modalities.

Study Overview

Status

Completed

Conditions

Detailed Description

In this study, Q methodology was used to systematically examine dialysis patients' subjective experiences and perspectives regarding treatment modalities. Q methodology is a research method that combines qualitative and quantitative paradigms, requiring participants to rank statements expressing their thoughts on a specific topic according to their own perspectives.

Study Type

Observational

Enrollment (Actual)

26

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The hospital where the study will be conducted has a total of 13 adult peritoneal dialysis patients and 70 adult hemodialysis patients who regularly receive dialysis treatment and attend follow-up appointments. The aim is to study the entire peritoneal dialysis patient population. For hemodialysis patients, a similar number of patients (n=13) to the peritoneal dialysis patients will be selected using a simple randomization method, and these patients will be included in the study.

Description

Inclusion Criteria:

  • Being between 18-65 years of age,
  • Being able to read and write,
  • Not having vision or hearing problems,
  • Voluntary participation in our study,
  • Being conscious,
  • Being a patient with end-stage renal failure,
  • Not having communication problems

Exclusion Criteria:

• Wishing to withdraw from the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perception of dialysis treatment
Time Frame: up to 6 months
Hemodialysis patients were asked to rank 24 Q items, developed based on literature review and clinical experience, on a scale from -3 (strongly disagree) to +3 (strongly agree) according to a normal distribution model.
up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yuzuncu Yil University

Investigators

  • Principal Investigator: Yavuz Uren, PhD, Yuzuncu Yil University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 31, 2025

Primary Completion (Actual)

January 31, 2026

Study Completion (Actual)

January 31, 2026

Study Registration Dates

First Submitted

December 22, 2025

First Submitted That Met QC Criteria

January 7, 2026

First Posted (Actual)

January 8, 2026

Study Record Updates

Last Update Posted (Actual)

March 12, 2026

Last Update Submitted That Met QC Criteria

March 11, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PD-HD Q2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dialysis Patients

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe